Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 20:49 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001521111-26-000005 · form4-08212026_080836.xml · derivative · entry 3 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,000 Underlying: Class A Common Stock · 100,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:49 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
SaleClass A Common Stock | 100,000 | $7.09 | $709,240.00 |
DisclosureSEC source: 0001521111-26-000005 · form4-08212026_080836.xml · nonDerivative · entry 2 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:49 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
Exercise / conversionClass A Common Stock | 100,000 | $1.87 | $187,000.00 |
DisclosureSEC source: 0001521111-26-000005 · form4-08212026_080836.xml · nonDerivative · entry 1 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 22:27 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0002039891-26-000008 · form4-07172026_100715.xml · derivative · entry 4 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,999 Underlying: Class A Common Stock · 1 shares Expires 2035-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 22:27 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 39,999 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0002039891-26-000008 · form4-07172026_100715.xml · derivative · entry 3 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662,333 Underlying: Class A Common Stock · 39,999 shares Expires 2034-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 22:27 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionClass A Common Stock | 1 | $1.97 | $1.97 |
DisclosureSEC source: 0002039891-26-000008 · form4-07172026_100715.xml · nonDerivative · entry 2 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 22:27 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionClass A Common Stock | 39,999 | $2.17 | $86,797.83 |
DisclosureSEC source: 0002039891-26-000008 · form4-07172026_100715.xml · nonDerivative · entry 1 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 47,668 | $0.00 Strike: $2.17 | $0.00 |
DisclosureSEC source: 0002039891-26-000006 · form4-06242026_110612.xml · derivative · entry 3 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 702,332 Underlying: Class A Common Stock · 47,668 shares Expires 2034-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Sauvage PhilippeChief Financial Officer
|
SaleClass A Common Stock | 47,668 | $6.01 | $286,370.28 |
DisclosureSEC source: 0002039891-26-000006 · form4-06242026_110612.xml · nonDerivative · entry 2 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,673 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.04. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Sauvage PhilippeChief Financial Officer
|
Exercise / conversionClass A Common Stock | 47,668 | $2.17 | $103,439.56 |
DisclosureSEC source: 0002039891-26-000006 · form4-06242026_110612.xml · nonDerivative · entry 1 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:09 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,620 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001734780-26-000004 · form4-06242026_110645.xml · derivative · entry 5 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,190 Underlying: Class A Common Stock · 34,620 shares Expires 2030-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:09 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 90,380 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001734780-26-000004 · form4-06242026_110645.xml · derivative · entry 4 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,620 Underlying: Class A Common Stock · 90,380 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:09 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
SaleClass A Common Stock | 125,000 | $6.03 | $753,187.50 |
DisclosureSEC source: 0001734780-26-000004 · form4-06242026_110645.xml · nonDerivative · entry 3 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,591 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.085. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:09 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
Exercise / conversionClass A Common Stock | 34,620 | $1.74 | $60,238.80 |
DisclosureSEC source: 0001734780-26-000004 · form4-06242026_110645.xml · nonDerivative · entry 2 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:09 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
Exercise / conversionClass A Common Stock | 90,380 | $1.87 | $169,010.60 |
DisclosureSEC source: 0001734780-26-000004 · form4-06242026_110645.xml · nonDerivative · entry 1 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 63,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001369453-26-000008 · form4-06242026_110649.xml · derivative · entry 3 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 152,250 Underlying: Class A Common Stock · 63,000 shares Expires 2032-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
SaleClass A Common Stock | 63,000 | $6.02 | $379,190.70 |
DisclosureSEC source: 0001369453-26-000008 · form4-06242026_110649.xml · nonDerivative · entry 2 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.08. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 23:07 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionClass A Common Stock | 63,000 | $2.93 | $184,590.00 |
DisclosureSEC source: 0001369453-26-000008 · form4-06242026_110649.xml · nonDerivative · entry 1 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2026 Filed Jun 12, 2026 00:02 UTC |
Mashal RobertDirector
|
PurchaseClass A Common Stock | 25,000 | $4.73 | $118,250.00 |
DisclosureSEC source: 0002007102-26-000004 · form4-06122026_120648.xml · nonDerivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 225,000 F1 · ownership.nature: Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:07 UTC |
Mashal RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0002007102-26-000002 · form4-05272026_120559.xml · derivative · entry 1 Mashal Robert · CIK 0002007102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:07 UTC |
VERNON W ANTHONYDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001369091-26-000003 · form4-05272026_120552.xml · derivative · entry 1 VERNON W ANTHONY · CIK 0001369091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:05 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001206977-26-000006 · form4-05272026_120546.xml · derivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:04 UTC |
BLICKENSTAFF KIM DDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001238913-26-000002 · form4-05272026_120529.xml · derivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:03 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001620152-26-000003 · form4-05272026_120523.xml · derivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| May 21, 2026 Filed May 27, 2026 00:01 UTC |
Cui XiangminDirector
|
GrantStock Option (Right to Buy) · Derivative | 123,397 | $0.00 Strike: $4.79 | $0.00 |
DisclosureSEC source: 0001487815-26-000007 · form4-05272026_120549.xml · derivative · entry 1 Cui Xiangmin · CIK 0001487815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,397 Underlying: Class A Common Stock · 123,397 shares Expires 2036-05-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:35 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,750 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001369453-26-000006 · form4-04212026_080412.xml · derivative · entry 3 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,250 Underlying: Class A Common Stock · 36,750 shares Expires 2032-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:35 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
SaleClass A Common Stock | 36,750 | $5.01 | $184,279.20 |
DisclosureSEC source: 0001369453-26-000006 · form4-04212026_080412.xml · nonDerivative · entry 2 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.05. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:35 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionClass A Common Stock | 36,750 | $2.93 | $107,677.50 |
DisclosureSEC source: 0001369453-26-000006 · form4-04212026_080412.xml · nonDerivative · entry 1 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 430,000 Underlying: Class A Common Stock · 50,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 50,000 | $5.02 | $251,000.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:34 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Stock | 50,000 | $1.94 | $97,000.00 |
DisclosureSEC source: 0001937915-26-000004 · form4-04212026_080401.xml · nonDerivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:23 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001369453-26-000005 · form4-04082026_080413.xml · derivative · entry 5 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,000 Underlying: Class A Common Stock · 100,000 shares Expires 2033-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:23 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001369453-26-000005 · form4-04082026_080413.xml · derivative · entry 4 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,000 Underlying: Class A Common Stock · 100,000 shares Expires 2034-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:23 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
SaleClass A Common Stock | 200,000 | $4.52 | $903,560.00 |
DisclosureSEC source: 0001369453-26-000005 · form4-04082026_080413.xml · nonDerivative · entry 3 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,000 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $4.44 to $4.64. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:23 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionClass A Common Stock | 100,000 | $1.94 | $194,000.00 |
DisclosureSEC source: 0001369453-26-000005 · form4-04082026_080413.xml · nonDerivative · entry 2 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 253,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2026 Filed Apr 8, 2026 20:23 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
Exercise / conversionClass A Common Stock | 100,000 | $1.87 | $187,000.00 |
DisclosureSEC source: 0001369453-26-000005 · form4-04082026_080413.xml · nonDerivative · entry 1 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:00 UTC |
Sauvage PhilippeChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0002039891-26-000003 · form4-03042026_010301.xml · derivative · entry 2 Sauvage Philippe · CIK 0002039891 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 20:01 UTC |
Sjogren ColleenChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0002017751-26-000003 · form4-03042026_010344.xml · derivative · entry 2 Sjogren Colleen · CIK 0002017751 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:03 UTC |
Makunje MosesSEE REMARKS
|
GrantStock Option (Right to Buy) · Derivative | 224,439 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0002001938-26-000004 · form4-03042026_010328.xml · derivative · entry 2 Makunje Moses · CIK 0002001938 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,439 Underlying: Class A Common Stock · 224,439 shares Expires 2036-02-26 F3 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:03 UTC |
Makunje MosesSEE REMARKS
|
GrantClass A Common Stock | 50,761 | $0.00 | $0.00 |
DisclosureSEC source: 0002001938-26-000004 · form4-03042026_010328.xml · nonDerivative · entry 1 Makunje Moses · CIK 0002001938 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,137 F1 · shares: Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date. F2 · balance_after: Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 19:52 UTC |
Hanley David C.CHIEF TECHNICAL OPERATIONS
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001865826-26-000003 · form4-03042026_120316.xml · derivative · entry 1 Hanley David C. · CIK 0001865826 · CHIEF TECHNICAL OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:04 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001937915-26-000003 · form4-03042026_010341.xml · derivative · entry 1 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:02 UTC |
Wentworth KerryCHIEF REGULATORY OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001369453-26-000003 · form4-03042026_010334.xml · derivative · entry 2 Wentworth Kerry · CIK 0001369453 · CHIEF REGULATORY OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:59 UTC |
Markel StacyCHIEF PEOPLE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001734780-26-000003 · form4-03042026_120307.xml · derivative · entry 2 Markel Stacy · CIK 0001734780 · CHIEF PEOPLE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F2 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:58 UTC |
Cui XiangminDirector
|
GrantStock Option (Right to Buy) · Derivative | 74,813 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001487815-26-000003 · form4-03042026_120305.xml · derivative · entry 1 Cui Xiangmin · CIK 0001487815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,813 Underlying: Class A Common Stock · 74,813 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:57 UTC |
Hattersley GaryCHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 748,130 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001521111-26-000003 · form4-03042026_120312.xml · derivative · entry 1 Hattersley Gary · CIK 0001521111 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 748,130 Underlying: Class A Common Stock · 748,130 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 00:50 UTC |
Hung DavidDirector · PRESIDENT AND CEO · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 1,995,012 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001310880-26-000003 · form4-03042026_120352.xml · derivative · entry 1 Hung David · CIK 0001310880 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,995,012 Underlying: Class A Common Stock · 1,995,012 shares Expires 2036-02-26 F1 · derivative.exercise_date: Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Read SEC document |
| February 27, 2026 Filed May 27, 2026 00:01 UTC Amendment |
Cui XiangminDirector
|
GrantStock Option (Right to Buy) · Derivative | 76,923 | $0.00 Strike: $5.91 | $0.00 |
DisclosureSEC source: 0001487815-26-000006 · form4a-05272026_120510.xml · derivative · entry 1 Cui Xiangmin · CIK 0001487815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,923 Underlying: Class A Common Stock · 76,923 shares Expires 2036-02-26 F1 · shares: On March 3, 2026, the reporting person filed a Form 4 which, due to an administrative error, incorrectly reported that the reporting person was awarded 74,813 options to purchase Class A Common Stock on February 27, 2026. In fact, the reporting person was awarded 76,923 options to purchase Class A Common Stock on such date. F2 · derivative.exercise_date: Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · derivative · entry 3 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,000 Underlying: Class A Common Stock · 150,000 shares Expires 2032-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 22:02 UTC |
Liu DongfangCHIEF MEDICAL OFFICER
|
SaleClass A Common Stock | 150,000 | $7.82 | $1,173,255.00 |
DisclosureSEC source: 0001937915-25-000010 · form4-12032025_101208.xml · nonDerivative · entry 2 Liu Dongfang · CIK 0001937915 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.